Sharing our four-pronged approach to TGA's requirements with NutraIngredients Asia

Update, October 2026. TGO 92 has been replaced. The Therapeutic Goods (Standard for Labelling of Non-Prescription Medicines) (TGO 116) Order 2026 commenced on 30 September 2026 and is now the labelling order for listed and other non-prescription medicines, with a transition period for labels already on the market. The four steps below still hold; read "TGO 92" as "TGO 116" and check the current order before any label change. Our TGO 116 labelling guide and what changed from TGO 92 cover it.

NutraIngredients Asia interviewed the Take Friday Off team about the TGA's new health-claim rules, the challenges sponsors face, and the approach we use with brands dealing with Permitted Indications and TGO 92. The full interview is on NutraIngredients Asia, and our press page lists the rest of our coverage. The short version:

1. Update the evidence. Make sure the evidence behind each product is current and meets the current evidence standard.
2. Select permitted indications and update the ARTG. Choose claims from the permitted indications list and update the product's health claims on the Australian Register of Therapeutic Goods.
3. Update the label. Revise the label with the new health claims, to the new labelling order.
4. Verify the label against the registration. Confirm that what is on the label matches what is registered on the ARTG.

Compliance is a growth lever when it is integrated from the start. This is the same logic that sits inside the Take Friday Off system today: regulatory work runs in parallel with formulation and sourcing, not after them.